
A D-retro-inverso peptide designed to selectively target senescent cells by disrupting the p53-FOXO4 interaction. A novel senolytic compound studied for aging and tissue homeostasis research.
For Research Use Only. This product is not intended for human consumption. By purchasing, you confirm this product will be used for research purposes only.
99%+ Purity
HPLC Verified
Fast Shipping
2-3 Day Delivery
FOX04-DRI is a D-retro-inverso peptide specifically designed to disrupt the FOXO4-p53 interaction — a critical signaling axis that maintains cellular senescence. This innovative peptide has generated significant excitement in the longevity and senolytics research community.
FOX04-DRI competitively binds to p53, preventing its sequestration by FOXO4. This restores p53's ability to trigger apoptosis selectively in senescent cells while sparing healthy cells. Published research in Cell demonstrated improvements in physical fitness, renal function, and tissue quality in aged models.
For research use only — not for human consumption.

A 28-amino acid immunomodulatory peptide naturally produced by the thymus gland. Extensively researched for T-cell maturation, dendritic cell activation, and immune regulation.

A naturally occurring tripeptide-copper complex that modulates the expression of over 4,000 human genes. Researched for tissue regeneration, wound healing, and antioxidant activity.

A synthetic tetrapeptide based on the pineal gland peptide Epithalamin. Studied for its effects on telomerase activation, melatonin regulation, and aging biomarkers.

A synthetic tripeptide bioregulator that crosses the blood-brain barrier. Researched for neuroprotective effects against oxidative stress and beta-amyloid toxicity in neuronal models.